Inventor · disambiguated record
Robin Buckingham
Also filed as: BUCKINGHAM ROBIN E · BUCKINGHAM ROBIN EDWIN
11 granted patents·25 pending applications·168 citations·filing 1982–2004
91Inventor score
Files withSMITHKLINE BEECHAM PLC20BEECHAM GROUP PLC9SMITHKLINE BEECHAM P 1 C1SMITHKLINE BEECHAM P L C & SMI1SMITHKLINE BEECHAM P L C AND S1
Top patents by PatentIndex Score
36 records- 0191US4446113ABenzopyransBEECHAM GROUP PLC·Filed 1982·Granted May 1, 1984·49 cites·25 claims
- 0287US6613785B2Use of glucose uptake enhancer for reducing post-ischemic injury of the heartSMITHKLINE BEECHAM PLC·Filed 2003·Granted Sep 2, 2003·22 cites·10 claims
- 0386US4542149A4-Amino-benzo[b]pyran-3-ol derivativesBEECHAM GROUP PLC·Filed 1983·Granted Sep 17, 1985·16 cites·11 claims
- 0484US5032591APharmaceutical preparationsBEECHAM GROUP PLC·Filed 1989·Granted Jul 16, 1991·35 cites·17 claims
- 0582US4610992ATrans-4-(2-thiaoxo-1-pyrrolidinyl or piperidinyl)-2H-benzo[b]pyran-3-ol derivatives useful in treating hypertensionBEECHAM GROUP PLC·Filed 1984·Granted Sep 9, 1986·14 cites·9 claims
- 0677US4555509AAnti-hypertensive benzo[b]pyran-3-olsBEECHAM GROUP PLC·Filed 1984·Granted Nov 26, 1985·10 cites·11 claims
- 0771US4644070AChroman-3-ol compoundsBEECHAM GROUP PLC·Filed 1984·Granted Feb 17, 1987·6 cites·3 claims
- 0870US6699889B2Use of glucose uptake enhancer for reducing post-ischemic injury of the heartSMITHKLINE BEECHAM PLC·Filed 2003·Granted Mar 2, 2004·2 cites·14 claims
- 0964US2004192737A1Use of thiazolidinediones for the treatment of hyperglycaemiaSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 1063US2004176420A1Treatment of diabetes with thiazolidinedione and sulphonylureaSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 1161US2004254229A1Use of glucose uptake enhancer for reducing apoptosisSMITHKLINE BEECHAM P L C AND S·Filed 2004·Application pending·0 cites
- 1260US2004176373A1Novel method of treatmentSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 1360US2004122060A1Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanideSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 1460US2003109561A1Treatment of diabetes with thiazolidinedione and sulphonylureaSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 1560US2003069283A1Use of thiazolidinediones for the treatment of hyperglycaemiaSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 1660US2004110800A1Use of glucose uptake enhancer for reducing post-ischemic injury of the heartSMITHKLINE BEECHAM P L C & SMI·Filed 2003·Application pending·0 cites
- 1759US2003109552A1Use of insulin sensitisers for treating renal diseasesSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 1858US2003069282A1Use of glucose uptake enhancer for reducing apoptosisSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 1958US2002137773A1Use of thiazolidinediones for the treatment of hyperglycaemiaSMITHKLINE BEECHAM P 1 C·Filed 2002·Application pending·0 cites
- 2057US2003092750A1Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitorSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 2157US2002156106A1Use of insulin sensitisers for treating renal diseasesSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 2257US2002045649A1Treatment of diabetes with thiazolidinedione and sulphonylureaSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2357US2002082284A1Use of thiazolidinediones for the treatment of hyperglycaemiaFiled 2002·Application pending·0 cites
- 2456US4738963AMethod for the treatment of incontinence in mammalsBEECHAM GROUP PLC·Filed 1986·Granted Apr 19, 1988·10 cites·14 claims
- 2556US2001031776A1Use of thiazolidinediones for the treatment of hyperglycaemiaSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2656US2002099082A1Use of glucose uptake enhancer for reducing apoptosisSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 2756US2002006939A1Use of thiazolidinediones for the treatment of hyperglycaemiaSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2854US2002052324A1Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitorSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2954US2001044458A1Use of insulin sensitisers for treating renal diseasesSMITHKLINE BEECHAMP P L C·Filed 2001·Application pending·0 cites
- 3053US2002016287A1Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanideSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 3151US2003060489A1Novel method of treatmentFiled 2000·Application pending·0 cites
- 3249US2003125358A1Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparationSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 3347US2002115699A1Method for treating renal diseaseSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 3445US4647670ATrans-3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-oxo-pyrrolidinyl)2H-1-benzopyran-3-olBEECHAM GROUP PLC·Filed 1984·Granted Mar 3, 1987·1 cites·1 claims
- 3539US2004266833A1Novel use of certain insulin sensitizers or ppar-gamma agonistsFiled 2001·Application pending·0 cites
- 3630US4789679AMethod for treating incontinenceBEECHAM GROUP PLC·Filed 1987·Granted Dec 6, 1988·3 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →